Myelodysplastic Syndrome Clinical Trial
Study of Quality of Life in Older vs. Younger Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes
Summary
This is a multi-center, Phase II, cross-sectional study comparing quality of life (QOL) as assessed by patient-reported outcomes (PROs) in older (≥65 years) adults vs younger (55-64 years) undergoing allogeneic hematopoietic cell transplantation (HCT) for myelodysplastic syndromes (MDS).
Full Description
Transplant recipients who have met the inclusion and exclusion criteria and from participating study sites will be asked to complete an online consent and survey for the study. This survey is the patient-reported outcomes survey and will be used to assess quality of life. The survey results will then be compared by age group and by time post transplant, between 6 months and a year post transplant, 1 year to 3 years post transplant, and 3 years or more post transplant.
Eligibility Criteria
Inclusion Criteria:
In order to be eligible to participate on this study, an individual must meet all of the following criteria:
Underwent an allogeneic HCT for MDS on the 10-CMSMDS-1 protocol
Prior consent to research and future contact by the CIBMTR
Ability to provide RCI BMT protocol 17-ePRO signed and dated informed consent form (ICF)
Age ≥55 years at time of transplant
Fluent in English or Spanish
Greater than 6 months post-HCT
Exclusion Criteria:
An individual who meets any of the following criteria will be excluded from participation on this study.
No access to an internet browser or email account
Within 6 months of first HCT for MDS on the 10-CMSMDS-1 protocol
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 6 Locations for this study
Stanford California, 94304, United States
Tampa Florida, 33612, United States
Detroit Michigan, 48201, United States
New York New York, 10065, United States
Columbus Ohio, 43210, United States
Milwaukee Wisconsin, 53226, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.